News & Updates
Filter by Specialty:
Inhaled insulin beneficial in youth with diabetes
Inhaled insulin appears to be equally efficacious and safe as the injected rapid-acting insulin analogue in children and adolescents with diabetes, according to data from the INHALE-1 study.
Inhaled insulin beneficial in youth with diabetes
22 Jul 2025
Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist
For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.
Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist
21 Jul 2025
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
Exercise prevents death in diabetes patients with MI
Regularly engaging in any physical activity (PA) can help reduce the risk of death in patients with diabetes and myocardial infarction (MI), suggests a study presented at ADA 2025.
